Amryt Pharma plc - American Depositary Shares (NQ:AMYT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 11, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Amryt Pharma plc - American Depositary Shares

< Previous 1 2 3 Next >

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

March 14, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗

January 18, 2023

Via Benzinga

Why Shares of Amryt Pharma Jumped This Week ↗

January 12, 2023

A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.

Via The Motley Fool

Recap: Amryt Pharma Q3 Earnings ↗

November 03, 2022

Amryt Pharma (NASDAQ:AMYT) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Filsuvez's European Approval Adds Growth Driver For Amryt Pharma ↗

June 24, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗

January 10, 2023

Via Benzinga

Recap: Amryt Pharma Q1 Earnings ↗

May 04, 2022

Amryt Pharma (NASDAQ:AMYT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Amryt Shares Trading Higher As EMA Endorses Approval Of Filsuvez In Genetic Skin Disease ↗

April 22, 2022

Via Benzinga

S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher ↗

January 09, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday.

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

Amryt Posts Long-Term Safety, Efficacy Mycapssa Data In Acromegaly Patients ↗

April 13, 2022

Amryt Pharma Plc (NASDAQ: AMYT) has

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 09, 2023

Via Benzinga

Nasdaq Surges Over 200 Points; Crude Oil Rises 2% ↗

January 09, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.

Via Benzinga

Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday ↗

January 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Open Higher; Dow Rises 150 Points ↗

January 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023 ↗

January 09, 2023

Via Benzinga

Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday ↗

January 09, 2023

Via Benzinga

Italian Privately Held Chiesi Farmaceutici To Acquire Amryt Pharma For $1.25B ↗

January 09, 2023

Italian family-controlled global pharmaceutical company Chiesi Farmaceutici S.p.A. has agreed to acquire Amryt Pharma Plc (NASDAQ: AMYT) for an implied value of $1.25 billion in upfront consideration.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 09, 2023

Via Benzinga

Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 09, 2023

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗

September 08, 2022

Via Benzinga

Amryt Secures UK Regulatory Nod And Orphan Disease Status For Skin Disorder Candidate ↗

September 08, 2022

The Medical Healthcare & Products Regulatory Agency (MHRA) has granted Marketing Authorisation Approval (MAA) and Orphan Disease Designation (ODD) for Amryt’s (NASDAQ: AMYT) lead candidate Filsuvez for...

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 14, 2022

Via Benzinga

Amryt Shares Shoot Higher As FDA Grants Orphan Drug Status To Carcinoid Tumor Candidate ↗

July 14, 2022

The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Amryt’s (NASDAQ: AMYT) lead drug Mycapssa for the treatment of carcinoid syndrome. Carcinoid syndrome (CS) is the most...

Via Benzinga

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise ↗

June 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 23, 2022

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

Amryt Pharma's Q4 FY21 Sales, FY22 Guidance Shy Of Street Consensus ↗

March 09, 2022

Amryt Pharma Plc's (NASDAQ: AMYT) Q4 FY21 sales increased 29% Y/Y to $54.8 million, missing the consensus of $56.81 million. The growth was driven by metreleptin...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.